Johanna Faris
Algemeen Adviseur bij SENZIME AB
Vermogen: 754 $ op 30-04-2024
Profiel
Johanna Faris is currently the Director of Quality Assurance & Regulatory Affairs at Senzime AB since 2018.
Prior to this, she worked as the Director of Regulatory & Quality Assurance at Biovica International AB from 2016 to 2018.
She also worked as a Manager of Quality Assurance & Regulatory at Fiomi Diagnostics AB.
Ms. Faris completed her undergraduate degree at the University of Uppsala.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
SENZIME AB
0.00% | 30-12-2022 | 1 183 ( 0.00% ) | 754 $ | 30-04-2024 |
Actieve functies van Johanna Faris
| Bedrijven | Functie | Begin |
|---|---|---|
| SENZIME AB | Algemeen Adviseur | 01-01-2018 |
Eerdere bekende functies van Johanna Faris
| Bedrijven | Functie | Einde |
|---|---|---|
| BIOVICA INTERNATIONAL AB | Algemeen Adviseur | 01-08-2018 |
Fiomi Diagnostics AB
 Fiomi Diagnostics AB Medical SpecialtiesHealth Technology Part of MiCo IVD Holdings, LLC, Fiomi Diagnostics AB is a Swedish company that develops, manufactures, and markets diagnostic test kits. The company is based in Uppsala, Sweden. Fiomi Diagnostics was acquired by Trinity Biotech Plc on March 01, 2012 for $13.12 million. | Algemeen Adviseur | - |
Opleiding van Johanna Faris
| University of Uppsala | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| BIOVICA INTERNATIONAL AB | Health Technology |
| SENZIME AB | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Fiomi Diagnostics AB
Fiomi Diagnostics AB Medical SpecialtiesHealth Technology Part of MiCo IVD Holdings, LLC, Fiomi Diagnostics AB is a Swedish company that develops, manufactures, and markets diagnostic test kits. The company is based in Uppsala, Sweden. Fiomi Diagnostics was acquired by Trinity Biotech Plc on March 01, 2012 for $13.12 million. | Health Technology |
